Emergency Open 24/7 · Morning OPD from 9:00 AM
    10-Bedded Hospital✦24/7 Emergency Care✦+91 90633 66983✦+91 95053 74057✦❤️ Best Neurologist in Hyderabad✦✦10-Bedded Hospital✦24/7 Emergency Care✦+91 90633 66983✦+91 95053 74057✦❤️ Best Neurologist in Hyderabad✦✦
    Back to all articlesNeurology

    Chronic Migraine: When Migraine Becomes a Daily Burden — Causes and Modern Treatment

    Dr. Anand Karnam 2026-05-25 5 min
    Chronic Migraine: When Migraine Becomes a Daily Burden — Causes and Modern Treatment

    Chronic migraine means 15+ headache days per month for 3+ months. It is distinct from episodic migraine and requires a different treatment strategy. Dr. Anand Karnam explains the transition and how to break the cycle.

    Key Points

    • Chronic migraine = headache ≥15 days/month for >3 months, with migraine features ≥8 of those days.
    • MOH (medication overuse) must be excluded and treated before preventive therapy is started.
    • Topiramate and propranolol are most used oral preventives — effective in 50% of chronic migraine patients.
    • OnabotulinumtoxinA (Botox) injections every 12 weeks are approved for chronic migraine — 30 injection protocol.
    • CGRP monoclonal antibody injections (monthly or quarterly) represent the newest highly effective preventive class.

    15 days/month

    headache frequency threshold for chronic migraine diagnosis

    Source: ICHD-3

    50%

    of patients on Botox injections achieve ≥50% reduction in headache days

    Source: NCBI

    60%

    of chronic migraine has medication overuse as a contributing factor

    Source: AAN

    "Chronic migraine is not failure of the patient — it is a biological phenomenon of central sensitisation that develops from undertreated episodic migraine. The goal of treatment is to reverse this sensitisation with consistent, sustained preventive therapy."

    — Dr. Anand Karnam · DrNB Neurology · Sri Anand CNC, Chanda Nagar Hyderabad, Sri Anand Child and Neuro Center

    Episodic migraine — attacks occurring fewer than 15 days per month — affects approximately 10–12% of Indians. But chronic migraine — 15 or more headache days per month, with at least 8 of those meeting migraine criteria, for more than 3 months — is a more severe and disabling condition affecting an estimated 2–3% of the population. The transition from episodic to chronic migraine is largely preventable, yet most patients do not recognise the warning signs until they are already trapped in a daily headache cycle.

    How Episodic Migraine Becomes Chronic

    The primary driver of chronification is medication overuse. When migraine patients use acute medications (paracetamol, triptans, NSAIDs, opioids) on more than 10–15 days per month, the medication itself begins to cause headache — medication overuse headache (MOH), also called rebound headache. The brain becomes sensitised to headache in response to medication withdrawal. Other risk factors for chronification: untreated or undertreated migraine attacks; sleep disorders; obesity; caffeine overuse; stressful life events; depression and anxiety (bidirectional relationship — migraine and mood disorders each worsen the other).

    Treatment of Chronic Migraine

    Preventive medication is mandatory: topiramate (50–100mg at night), amitriptyline (10–75mg), propranolol, valproate, or flunarizine. These reduce headache frequency by 50% in most responders — but must be taken daily for 3–6 months before full effect is judged.

    OnabotulinumtoxinA (Botox): Injected into 31 points across the head and neck every 12 weeks. NICE-approved and evidence-based for chronic migraine. Reduces headache days by 8–9 per month. Now available in Hyderabad.

    CGRP monoclonal antibodies (erenumab, fremanezumab): Monthly subcutaneous injections targeting the CGRP pathway — the most recent advance in migraine prevention. Highly effective with minimal side effects. Increasingly available in India.

    MOH withdrawal: If medication overuse is present, the overused medication must be withdrawn — this is uncomfortable but essential. Guided withdrawal in a structured programme achieves significantly better outcomes. Sri Anand CNC, Chanda Nagar, Hyderabad. Call +91 90633 66983.

    Have questions about this topic?

    Our specialist doctors at Sri Anand Child and Neuro Center can help — in person or via WhatsApp.

    K

    Dr. Anand Karnam

    DrNB Neurology · Sri Anand CNC, Chanda Nagar Hyderabad · Sri Anand Child and Neuro Center

    DrNB-qualified Neurologist, Fellow of the World Headache Society (FWHS), and Headache Specialist with 12+ years of experience treating epilepsy, stroke, migraine, and movement disorders. Practices at Sri Anand Child and Neuro Center, Chanda Nagar, Hyderabad.

    References & Sources

    1. 1.Chronic Daily Headache — NCBI StatPearls — NCBI StatPearls
    2. 2.Headache Disorders — WHO Fact Sheet — World Health Organization
    3. 3.Migraine Prevention — AAN Guidelines — American Academy of Neurology

    Health Information Standards

    IMA — Indian Medical Association

    Content follows IMA ethical guidelines for patient education

    WHO — World Health Organization

    Treatment information aligned with WHO clinical guidelines

    MoHFW — Govt. of India — Ministry of Health

    Follows MoHFW National Health Programme protocols

    NMC — National Medical Commission

    All doctors hold NMC-recognised qualifications (DrNB / MD / MPT)

    All health tips and medical content on this website are written by qualified specialist doctors (DrNB / MD / MPT), follow the above guidelines, and are intended for general health education only. This content is original and evidence-based — not a substitute for professional medical advice. Always consult your doctor before making any health decisions.

    Concerned about your health?

    Talk to our specialist doctors directly — WhatsApp response within minutes during clinic hours.

    Share:WhatsAppFacebook

    Talk to a Specialist

    Dr. Anand (Neuro) · Dr. Sushma (Paeds) · Dr. Harisha (Physio)

    Verified Health Info

    IMA GuidelinesWHO GuidelinesMoHFW GuidelinesNMC Guidelines